Manufacturer of Controlled Substances; Notice of Registration, 9615 [2010-4403]

Download as PDF Federal Register / Vol. 75, No. 41 / Wednesday, March 3, 2010 / Notices DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated October 16, 2009, and published in the Federal Register on October 28, 2009, (74 FR 55587), American Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug mstockstill on DSKH9S0YB1PROD with NOTICES [FR Doc. 2010–4403 Filed 3–2–10; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE I I I I I I I I II II II II II II II II II II II II II II II II II II II II II The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of American Radiolabeled Chemical, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemical Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical 16:08 Mar 02, 2010 Dated: February 24, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Schedule Gamma Hydroxybutyric Acid (2010) ........................................ Ibogaine (7260) ............................ Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ...... Dimethyltryptamine (7435) ........... 1-[1-(2– Thienyl)cyclohexyl]piperidine (7470) ........................................ Dihydromorphine (9145) ............... Normorphine (9313) ..................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Amobarbital (2125) ....................... Phencyclidine (7471) .................... Phenylacetone (8501) .................. Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Ecgonine (9180) ........................... Hydrocodone (9193) ..................... Meperidine (9230) ........................ Metazocine (9240) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273) ............... Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) .................... Phenazocine (9715) ..................... Fentanyl (9801) ............................ VerDate Nov<24>2008 security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Jkt 220001 Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Registration By Notice dated October 21, 2009, and published in the Federal Register on October 28, 2009, (74 FR 55588), Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Frm 00044 Fmt 4703 The company plans to manufacture the listed controlled substances in bulk for sale to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: February 24, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–4404 Filed 3–2–10; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Office of the Secretary Schedule Gamma Hydroxybutyric Acid (2010) ........................................ Tetrahydrocannabinols (7370) ...... Dihydromorphine (9145) ............... Difenoxin (9168) ........................... Propiram (9649) ............................ Amphetamine (1100) .................... Methamphetamine (1105) ............ Lisdexamfetamine (1205) ............. Methylphenidate (1724) ................ Nabilone (7379) ............................ Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Ecgonine (9180) ........................... Hydrocodone (9193) ..................... Meperidine (9230) ........................ Methadone (9250) ........................ Methadone intermediate (9254) ... Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) .................... Noroxymorphone (9668) ............... Alfentanil (9737) ........................... Remifentanil (9739) ...................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ PO 00000 9615 Sfmt 4703 Bureau of International Labor Affairs: Labor Advisory Committee for Trade I Negotiations and Trade Policy I I I I II II II II II II II II II II II II II II II II II II II II II II II ACTION: Meeting Notice. SUMMARY: Pursuant to the provisions of the Federal Advisory Committee Act (Pub. L. 92–463, as amended), notice is hereby given of a meeting of the Labor Advisory Committee for Trade Negotiation and Trade Policy. Date, Time, Place: March 16, 2010; 10:30 a.m.–11:30 a.m.; U.S. Department of Labor, Secretary’s Conference Room, 200 Constitution Ave., NW., Washington, DC. Purpose: The meeting will include a review and discussion of current issues which influence U.S. trade policy. Potential U.S. negotiating objectives and bargaining positions in current and anticipated trade negotiations will be discussed. Pursuant to 19 U.S.C. 2155(f) it has been determined that the meeting will be concerned with matters the disclosure of which would seriously compromise the Government’s negotiating objectives or bargaining E:\FR\FM\03MRN1.SGM 03MRN1

Agencies

[Federal Register Volume 75, Number 41 (Wednesday, March 3, 2010)]
[Notices]
[Page 9615]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4403]



[[Page 9615]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 16, 2009, and published in the Federal 
Register on October 28, 2009, (74 FR 55587), American Radiolabeled 
Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedules I and II:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010).............................          I
Ibogaine (7260)..............................................          I
Lysergic acid diethylamide (7315)............................          I
Tetrahydrocannabinols (7370).................................          I
Dimethyltryptamine (7435)....................................          I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).................          I
Dihydromorphine (9145).......................................          I
Normorphine (9313)...........................................          I
Amphetamine (1100)...........................................         II
Methamphetamine (1105).......................................         II
Amobarbital (2125)...........................................         II
Phencyclidine (7471).........................................         II
Phenylacetone (8501).........................................         II
Cocaine (9041)...............................................         II
Codeine (9050)...............................................         II
Dihydrocodeine (9120)........................................         II
Oxycodone (9143).............................................         II
Hydromorphone (9150).........................................         II
Ecgonine (9180)..............................................         II
Hydrocodone (9193)...........................................         II
Meperidine (9230)............................................         II
Metazocine (9240)............................................         II
Dextropropoxyphene, bulk (non-dosage forms) (9273)...........         II
Morphine (9300)..............................................         II
Oripavine (9330).............................................         II
Thebaine (9333)..............................................         II
Oxymorphone (9652)...........................................         II
Phenazocine (9715)...........................................         II
Fentanyl (9801)..............................................         II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances as radiolabeled compounds for biochemical 
research.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
American Radiolabeled Chemical, Inc. to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated American Radiolabeled Chemical Inc. 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823, and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: February 24, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-4403 Filed 3-2-10; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.